Table 2.
Definition of clinically relevant differences in glycated hemoglobin.
| Reduction rate in glycated hemoglobin (%) | P value | Guidance |
| ≤−0.5 | >.05 |
a
|
| >−0.5, <0 | >.05 |
b
|
| >0 | >.05 |
c
|
| >−0.5, <0 | <.05 |
d
|
| ≤−0.5 | <.05 |
e
|
anon-significant but clinically relevant change.
bnon-significant and not clinically relevant change.
cnon-significant and not clinically relevant change.
dsignificant but not clinically relevant change.
esignificant and clinically relevant change.
a
b
c
d
e